Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchPC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
“AI-designed” is a description of how a drug candidate was generated, not proof that it works in patients. To judge credibility, identify exactly what the artificial-intelligence system did, then follow the evidence from data and independent testing through laboratory studies, toxicology, manufacturing, and appropriately designed human trials. A molecule ranked highly by a model may still fail because it is inactive in a real assay, cannot be made consistently, has unacceptable toxicity, or does not improve patient outcomes.
The most reliable approach is layered: define the model’s context of use; inspect data provenance, leakage controls, calibration, uncertainty, and subgroup performance; look for external and prospective evaluation; and verify the ordinary pharmacology, safety, quality, and efficacy package expected of any cancer medicine. The January 2025 FDA draft framework treats credibility as confidence that a model performs adequately for a specified use, not as a blanket endorsement of “AI in drug discovery.”
What does “AI-designed cancer drug” actually mean?
The phrase can describe several very different activities. Before judging a headline, determine whether the system generated a biological target, proposed a chemical structure, predicted activity or toxicity, selected patients, designed a trial, analyzed trial data, or produced an output used in a regulatory decision. Those uses have different failure modes and require different evidence.
Recommended Free Tools
Target discovery
An algorithm may identify a protein, mutation, pathway, or biomarker that appears worth pursuing. This is a hypothesis about biology. It does not show that a drug can bind the target, that the target is selective for cancer cells, or that changing it helps patients.
#1 Best Overall
- Powerful Turbo Fan:CAGIWIRU Electric Air Duster have reached speed up to 130000RPM,Can efficient remove dust and debris.With LED light and Three Adjustable Speed to meet with different cleaning tasks.
- With Attached USB C Fasting Charging cable.Charing 3 hours,Enjoy up to 240 minutes of use on the lowest setting, For third speed can use for 25mins.with four charging options to meet with your needs.
- Wide Application: attached 5 different nozzles,making it suitable for a variety of scenes, such as car,pet, pc, keyboards, and other electronic devices. It also serves for office and home clean duster.
- Handy Design & Portable:Cordless air duster electric nozzle is Light weight and small size, design and comfortable to hold and space saving, convenient to carry around. You can put it in your room or inside the car without taking up space.
- Economical &Reusable: Built durable materials with a long-lasting battery,our CAGIWIRU air duster it's a sustainable alternative to disposable air cans.
Molecule generation or ranking
A model can create novel structures or rank existing compounds by predicted potency, selectivity, solubility, or other properties. The output is a shortlist for laboratory work. Predictions must be confirmed with replicated assays, orthogonal methods, pharmacokinetic studies, and toxicology.
Patient, trial, or regulatory support
AI can also classify patients, recommend a dose, optimize a trial design, or analyze safety and efficacy data. In these settings the relevant question is not whether the model is creative; it is whether its output is reliable for the decision being made and whether human oversight catches consequential errors.
The key distinction
“AI-designed” identifies a method. “Clinically credible” describes an evidence chain. A credible claim states the intended cancer, population, endpoint, development stage, and decision the model informs, then supplies evidence proportionate to the risk of getting that decision wrong.
How do you define the AI system’s context of use?
Start by writing one sentence that specifies the decision, the users, and the conditions under which the output will be used. FDA describes credibility as trust in model performance for a particular context of use; without that boundary, a performance claim cannot be tested meaningfully.
A practical context-of-use statement
Include:
- Input: chemical structures, omics data, pathology images, clinical records, or another defined data type.
- Output: a ranked molecule list, a toxicity probability, a response prediction, a dose recommendation, or another precise result.
- Decision: which development or care decision the output informs.
- Population and disease: cancer type, disease stage, biomarker status, and inclusion criteria.
- Endpoint and time horizon: laboratory activity, progression-free survival, overall survival, serious adverse events, or another prespecified outcome.
- Human role: whether a scientist, clinician, sponsor, or regulator reviews and can override the output.
“Our model designs better cancer drugs” is too broad. “The model ranks compounds for inhibitory activity against a specified target in a defined biochemical assay, and scientists select candidates for testing” is narrow enough to evaluate.
Why context changes the evidence burden
A model used to prioritize experiments can be useful even when its predictions are imperfect, provided laboratory confirmation follows. A model that determines who receives an investigational treatment or supplies evidence for a safety decision has greater potential to harm patients, so it needs stronger validation, documentation, monitoring, and human review. Confidence should rise with demonstrated performance in the exact setting, not with the novelty of the algorithm.
What data and methods should a credible claim disclose?
A trustworthy report lets an independent reader understand where the data came from, how they were transformed, how the model was fitted, and how success was defined before results were viewed. The RSNA appraisal checklist emphasizes study purpose and clinical context, training and test data, preprocessing, modeling, performance, helpfulness, interpretability, and code sharing.
Quick wins for a faster PC:
Scan for outdated or missing drivers - takes under a minuteDriver Scan →Repair Windows errors before they cause bigger problemsFix Now →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Rank #2
- Screen Cleaner is Your Screen’s New Bestfriend! - EVEO is proud to present a screen cleaner that’s perfectly suited for your TV. Meet your new screen cleaner, computer screen cleaner, laptop cleaner, iPad cleaner, Macbook,tv cleaner or any other electronic device. Our screen cleaner spray and wipe along with the included plush microfiber cloth, easily removes dust, fingerprints & other smudges on the screen’s surface. Clean effectively for a streak-free screen
- Gentle on your Screens - Our screen cleaner spray and wipes is compatible to be used even for the most sensitive LCD, LED, CRT, and OLED screens in proper use. Be at ease knowing that this product is compatible with all the major brands: LG, SONY, Samsung, Sharp, iPad, iPhone, Android screens, Kindle, PC monitors - we’ve got you covered! Can be used as LCD screen cleaner, tv cleaner, smart tv screen cleaner, and more
- Premium Super Soft Plush Microfiber Cloth - Included in this efficient screen cleaning kit. This screen cleaner spray and wipe has our signature plush microfiber cloth specially designed to comply with screens and monitors and leave them streak-free. Has been shown to effectively absorbs stubborn stains, zero streaks, and no fiber shedding. Always use this together with our screen cleaner for the best results
- Easy-to-Use Screen Cleaner Kit + microfiber cleaning cloth - The EVEO Screen Cleaning Kit will easily be your new favorite tool when it comes to taking care of the things you love most, quick and easy solution for a streak-free screen. Simply screw on the sprayer gun on the screen cleaner bottle. Spray the cleaning liquid onto the microfiber cloth, then wipe the screen until desired cleanliness & shine is achieved.
- Quality Screen Care Kit Worth Purchasing - Enjoy a convenient Screen Cleaner anytime, anywhere you need it. Your satisfaction is our top priority. We stand behind the quality of our products and that’s why, you shouldn’t be worrying at all. We manufacture the Best Screen Cleaner. and can be used for laptop cleaning kit, laptop screen cleaner, tv screen cleaner for smart tv. MacBook screen cleaner, monitor cleaner or screen cleaner spray for electronic devices with microfiber cleaning cloth
Data provenance and representativeness
Identify who collected the data, when, under which inclusion criteria, and how closely it reflects the intended patients or compounds. For clinical data, disclose sites, scanners or laboratories when relevant, demographic composition, disease stage, treatment history, and missing-data handling. For chemical or assay data, describe assay type, measurement conditions, duplicate handling, and whether structures or experiments from the same source appear in both training and test sets.
Preprocessing and leakage controls
Preprocessing can silently alter results. Look for definitions of normalization, filtering, imputation, augmentation, and feature construction. Ask whether information from the test set, a later time period, or a patient’s future outcome could have entered training. Near-duplicate compounds, repeated patients, or images from one person split across sets can make an internal score look impressive while overstating generalization.
Model specification and prespecified criteria
The report should identify the model family, important hyperparameters, selection procedure, training process, and stopping rules. It should state the performance criteria chosen before evaluation, rather than selecting a favorable metric after trying many alternatives. Versioned models and executable specifications make it possible to determine exactly which system produced the result.
Uncertainty, calibration, and subgroups
A prediction should communicate how uncertain it is. Calibration asks whether predictions labeled, for example, as 70% likely correspond to the event about 70% of the time in the relevant population. Confidence intervals, prediction intervals, or other uncertainty estimates show how much results could vary. Report performance by clinically important subgroups, such as age, sex, ancestry, disease stage, biomarker status, site, or prior treatment, rather than only an overall average.
Replication and transparency
Code sharing is helpful, but proprietary code is not automatically disqualifying if the sponsor supplies a detailed method, locked model version, data dictionary, audit trail, and a feasible path for independent testing. A claim becomes more credible when an unaffiliated group reproduces it on data the developer did not select after seeing the result.
Is an internal test score enough?
No. A random train/test split from one source can estimate performance under similar conditions, but it does not establish that the system works at another institution, in another time period, or in the population that will receive the drug.
Internal validation
Cross-validation or a held-out test set is a useful first check when the split is genuinely independent and locked before analysis. It can reveal overfitting during development, but it remains vulnerable to shared collection practices, hidden duplicates, and a narrow population.
Rank #3
- 【Large size】：Measuring 800 x 300 mm/ 31. 5×12 inches, which is wider and taller than others. Large mouse pad can perfectly fit your keyboard and mouse of any size, and there is also ample space for peripherals such as phones, tablets, etc.
- 【LED backlight mouse pad】：Blade Hawks RGB mouse pad provides 7 static modes and 7 dynamic modes will give you the options you are looking for. Power-off memory function remembers the last lighting mode you selected. The super glow fiber Chroma will give you a colorful gaming setup that you want.
- 【Anti-slip rubber base】：Made from Natural rubber, this gaming mousepad will firmly grip your desktop, allowing you to enjoy the ultimate precision in the games you are most passionate about. It also comes with a texture that enhances this ability even further.
- 【Smooth and waterproof surface】: Micro-textured cloth surface, for extremely precise mouse control and a smooth movement. When liquid splashes on the gaming mouse pad, it forms water droplets and slides down. Will not delay your work or gameplay.
- 【Plug and play】: This mouse and keyboard pad is powered by USB, plug and play, no driver required. One button control light modes. Press one time to change the lighting mode, press twice to change the brightness, press and hold about 3 seconds turn ON/OFF.
External validation
Testing at independent sites, in a later time period, or in a different population is stronger evidence of transportability. Confirm that the sponsor did not choose the external set after reviewing predictions, and check whether the external setting reflects the intended use. The RSNA clinical-evaluation review states that adequate external testing is needed to confirm acceptable performance.
The Tool Desk
Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Prospective evaluation
Prospective studies evaluate the model on new cases as they arise, before the outcome is known. They can reveal workflow problems, shifts in laboratory practice, and performance degradation that retrospective data conceal. Prospective evaluation is desirable when the output affects patient management.
What to demand in the results
- Discrimination measures suited to the task, such as sensitivity, specificity, precision, or a rank-based measure.
- Calibration plots or statistics, not just a single discrimination number.
- Clinically meaningful thresholds and the trade-off between false positives and false negatives.
- Confidence intervals and the number of cases, compounds, or patients behind each estimate.
- Subgroup results and an explanation of missing or excluded observations.
- Prespecified analyses that distinguish exploratory findings from confirmatory claims.
A high area-under-the-curve value can coexist with poor calibration or little practical benefit. A small test set can also produce an unstable estimate with a wide interval, even when the headline number appears precise.
How can you tell whether the AI improves clinical decisions?
Performance is not the same as usefulness. The relevant comparison is what happens with the AI output versus the conventional process, using outcomes that matter to patients.
Paired clinician comparisons
In a paired design, clinicians make decisions with and without the AI on the same cases. This can show changes in diagnostic accuracy, treatment selection, or time, but it may not predict what happens in routine practice if clinicians receive more training or if the interface changes.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Parallel workflow comparisons
One group can use AI-assisted care while another follows conventional care. The groups should be comparable, and the analysis should specify how patients were assigned, which clinicians participated, and how deviations were handled.
Randomized trials
Randomization provides stronger evidence when the question is whether AI-assisted care improves patient outcomes. Prespecify endpoints, follow-up, safety monitoring, and analysis populations. A statistically significant difference is not automatically clinically important; report the absolute benefit, harms, and uncertainty.
Rank #4
- 【Softer and More Comfortable】Vaydeer wrist rest has unique diamond pattern, which is the combination of softness and aesthetics. The materials of wrist rest are improved into higher quality memory foam and covered with silky smooth lycra. The computer wrist rest makes you as comfortable and cushiony as like rest your wrists on clouds.
- 【Ergonomic Wrist Saver】The wrist rests for keyboard and mouse comes with a 17.32×3.15×0.83 inch keyboard wrist pad and a 5.94×3.15×0.83 inch mouse wrist support. Based on ergonomic design, the unique concave shape is the perfect fit for your wrist joints. The wrist rest pad fits most computer keyboards and laptops, improve hand and wrist posture, release your wrist and arm stress.
- 【Non-Slip Rubber Bottom】Featuring an anti-skid silicone base on the bottom, this wrist keyboard support stays firmly in place on your desk, preventing the padding from sliding around, ensuring stable and consistent wrist support during extended computer sessions.
- 【Better Experience & Pain Relief】Our keyboard arm rest is beneficial to alleviate the soreness caused by direct contact and friction between your arm and a hard desk surface, reducing the risk of wrist fatigue or carpal tunnel. The soft texture of memory foam can evenly distribute the pressure around your wrists and provide good support with just enough give.
- 【Helpful in Multiple Scenarios】Whether you're working, studying, writing, typing, gaming, this keyboard and mouse rest combo is an essential accessory to add comfort and support to your hands and wrists. It’s also a great gift for men, women, family, friend, coworker, gamer, teacher, etc.
Decision and outcome measures
Useful measures depend on the context: correct treatment selection, time to treatment, avoidable toxicity, response, progression-free survival, overall survival, quality of life, or serious adverse events. A faster workflow is not a patient benefit if it increases inappropriate treatment. The study should explain how AI recommendations were accepted, overridden, or ignored.
What conventional drug evidence is still required?
AI does not waive the normal requirements for a medicine. A model can accelerate candidate selection, but the molecule must still demonstrate a plausible mechanism, reproducible activity, acceptable exposure, manageable toxicity, manufacturability, and benefit in people.
| Development question | Evidence to look for | What an AI prediction cannot establish |
|---|---|---|
| Does the target matter? | Biological rationale, target engagement, and experiments that link modulation to the intended cancer effect | That the target is causal, selective, or clinically actionable |
| Does the molecule work? | Replicated primary assays and orthogonal confirmation in relevant cellular or disease models | That a predicted score equals real potency in patients |
| Is it selective and deliverable? | Off-target testing, pharmacokinetics, exposure data, formulation work, and tissue-distribution evidence where relevant | That the molecule reaches the tumor at an effective concentration |
| Is it safe enough to test? | Appropriate toxicology, safety pharmacology, dose-range work, and a rationale for first-in-human dosing | That a low predicted toxicity probability rules out human harm |
| Can it be made consistently? | Manufacturing controls, identity and purity specifications, stability, and quality documentation | That a generated structure can be produced at clinical quality |
| Does it help patients? | Well-designed human studies with interpretable safety and efficacy endpoints | That preclinical activity translates into response, survival, or quality-of-life benefit |
Follow the molecule, not only the model
Ask for the chain from computational output to lead selection: how many candidates were synthesized, how many failed, which assays confirmed the ranking, and why the clinical candidate was chosen. Selective reporting of the best-looking molecule can create survivorship bias. A credible account acknowledges negative or contradictory experiments and explains changes to the model or development plan.
Human evidence needs ordinary safeguards
For a clinical program, inspect the phase, enrollment criteria, dose-escalation design, comparator, follow-up, missing-data rules, and adverse-event reporting. Early safety and pharmacokinetic results can establish whether a compound is tolerable and reaches the intended exposure; they do not by themselves demonstrate efficacy. Later studies must show whether benefits outweigh harms for the stated cancer population.
What does the FDA framework say about AI credibility?
The FDA’s January 2025 document is a Level 1 draft guidance with nonbinding recommendations. It addresses AI outputs used to support decisions about drug safety, effectiveness, or quality and proposes a risk-based way to establish credibility for a specific context of use. It is a framework, not an approval or endorsement of any particular AI-designed cancer drug.
The agency reported more than 500 drug and biological-product submissions with AI components since 2016 and received more than 800 external comments on two discussion papers about AI in drug development and manufacturing. Those figures show broad use and regulatory attention; they do not show that the submissions were successful or that any particular model is reliable.
“The FDA is committed to supporting innovative approaches for the development of medical products by providing an agile, risk-based framework that promotes innovation and ensures the agency’s robust scientific and regulatory standards are met.” — Robert M. Califf, M.D., FDA Commissioner, January 6, 2025
Best Value
Sale
Under Desk Cable Management Tray No Drill, Metal Mesh Cable Management Under Desk with Clamp Mount, 2 Hole Cable Tray with Wire Management and Cord Organizer for Home Office Standing Desk
- 【No Drill Mounted】Cable management tray can be assembled in as little as 3 minutes or less-simply. Side clips easily clampe the edge of desk, pass through the holes on the sides, and secure excess cables with baskets. Desk cable management supports inward or outward installation to meet your needs in different scenarios, and provides you with great convenience when collecting and organizing wires.
- 【Rubber Pad Protects Desk】Wire organizer under desk built-in soft rubber pads on the clamp protect your desk from scratches, so you will not damage your furniture or office.
- 【Sturdy and Beautiful】Cord management under desk is made of high-quality carbon steel and holds about 15 lbs. The wire basket has 2 holes on each side of the tray to enable your cables to pass freely. Cable baskets are suitable for desk thickness use from 0.4" to 2.4".
- 【Space Saving & Keep Organized】Desk cable management tray holds all your power cords, outlet strips, USB hubs and computer transformers hidden from your feet, and the data cables will not enter the vacuum cleaner to keep your desk clean and tidy. Desk wire organizer is also suitable for use in the kitchen and outdoors.
- 【Reduce Safety Risks】Cable tray under desk keeps all plugs away from your kids, no more worry about tripping. Using 2 holes wire tray saves extra space, helps you easily cabling and wire protection. The mesh design is not easy to accumulate dust, but avoids safety accidents caused by messy wires.
Read the draft as guidance for documenting and evaluating AI-supported decisions. Do not treat it as a certification label, and do not infer approval from the fact that a sponsor mentions alignment with it.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What red flags suggest a headline is ahead of the evidence?
- The article says only “AI-designed” without naming the model’s decision, cancer, population, endpoint, or development stage.
- Results come solely from an internal split, with no independent site or later-time-period test.
- The denominator, confidence interval, subgroup results, or calibration information is missing.
- The sponsor reports a ranking or predicted potency as if it were a clinical result.
- There is no description of assay replication, selectivity, pharmacokinetics, toxicology, manufacturing quality, or dose selection.
- Patient-level outcomes are absent, or the release substitutes a surrogate without explaining its clinical relevance.
- The test set was assembled after the model or candidates were selected, or repeated measurements were treated as independent cases.
- No model version, human-review process, deviation log, or plan to monitor performance after deployment is described.
- Only favorable experiments are shown, while failed compounds, excluded patients, or protocol changes are unexplained.
- Regulatory language implies that a draft framework, submission, or meeting with an agency is equivalent to authorization.
How should you compare two competing AI-drug claims?
Compare like with like. A molecule-generation claim and a patient-selection claim cannot be ranked by the same metric, and a larger dataset is not automatically more representative.
| Comparison axis | Questions to ask |
|---|---|
| Context of use | What exact decision does the AI inform, for which cancer, population, endpoint, and stage? |
| Data provenance | Who collected the data, when, under what criteria, and how similar are they to intended use? |
| Independence | Was the test set locked in advance, and were sites or time periods independent of development? |
| Performance reporting | Are discrimination, calibration, uncertainty, thresholds, confidence intervals, and subgroups shown? |
| Clinical evaluation | Is there prospective testing, clinician comparison, a parallel workflow study, or randomization? |
| Reproducibility | Can an independent team run the specified model and verify the result? |
| Molecule evidence | Are target rationale, replicated assays, selectivity, pharmacokinetics, toxicology, dose, and manufacturing documented? |
| Patient benefit | What is the magnitude and clinical relevance of benefit, and what harms accompany it? |
| Independence and oversight | Who performed the evaluation, who funded it, and how are conflicts, overrides, and deviations handled? |
When evidence is mixed, prefer the claim with the narrower context, independent testing, transparent uncertainty, and stronger patient-level outcomes—even if its marketing language is less dramatic.
Free tools Windows power users keep installed
One-click scans. No signup required.
What is a practical step-by-step credibility check?
- Rewrite the headline as a testable claim. State the cancer, population, endpoint, AI output, and development stage.
- Map the AI’s role. Mark whether it generated a target, proposed or ranked molecules, predicted activity or toxicity, selected patients, designed a trial, or analyzed evidence.
- Trace the data. Record collection sites and dates, inclusion criteria, preprocessing, missing-data handling, and leakage safeguards.
- Check the split. Determine whether the test set was locked before modeling and whether duplicates, related compounds, or future information crossed the boundary.
- Read beyond the headline metric. Find calibration, uncertainty, confidence intervals, thresholds, subgroup results, and denominators.
- Look for external testing. Prefer independent institutions, later time periods, or different populations over another random split from the same source.
- Ask whether the workflow was tested prospectively. Check how users interacted with the output and how overrides or errors were recorded.
- Follow the candidate into the laboratory. Verify replicated and orthogonal assays, selectivity, pharmacokinetics, toxicology, and a rationale for dose selection.
- Inspect quality and manufacturing evidence. Confirm that the clinical material can be produced consistently and characterized to an appropriate standard.
- Evaluate human outcomes. Identify the trial phase, comparator, follow-up, safety findings, efficacy endpoints, absolute effects, and uncertainty.
- Check governance. Look for version control, human oversight, deviation logs, monitoring for performance drift, and independent replication.
- Match confidence to consequences. Require the strongest evidence where an erroneous output could expose patients to harm or influence a regulatory conclusion.
What evidence would justify increasing or decreasing confidence?
Confidence should increase when a narrowly defined claim is reproduced by an independent group, performs well on genuinely external data, remains calibrated across relevant subgroups, and improves a prespecified clinical or development outcome. For a molecule, replicated laboratory findings followed by coherent pharmacology, toxicology, manufacturing, and human data matter more than the sophistication of the model.
Confidence should decrease when results change substantially across sites, calibration is poor, uncertainty is hidden, key subgroups are missing, or the sponsor cannot explain exclusions and protocol changes. It should also fall when a computational score is presented as proof of efficacy without evidence that the candidate reaches the tumor, is tolerable, can be manufactured, and benefits patients.
Frequently Asked Questions
Can a proprietary AI model be credible if its source code is not public?
Yes, but the sponsor should provide a precise model specification, version history, data definitions, locked evaluation procedure, and enough executable detail for independent testing. Independent replication and transparent audit records are more informative than a public code repository by itself.
Does mention of FDA involvement mean an AI-designed drug is approved?
No. A submission, meeting, or statement that a sponsor follows FDA principles is not authorization. Approval applies to a product for a defined indication after review of quality, safety, and effectiveness evidence; it does not certify every AI component used during development.
Do these 3 things before closing this tab:
1Clear out junk files and repair common Windows errors2Scan for outdated or missing drivers - takes under a minute3Repair Windows errors before they cause bigger problemsWhat should a patient ask before joining a trial for an AI-discovered drug?
Ask what phase the trial is, what is known about human safety, how dosing was selected, what monitoring and stopping rules apply, and whether there is a comparator. Also ask which outcomes the study can establish and whether the AI’s role changes eligibility, treatment assignment, or data analysis.
Is a strong laboratory result enough to start human testing?
Laboratory activity is one part of the decision. Sponsors also need a defensible pharmacology and exposure plan, appropriate toxicology and safety studies, clinical-quality manufacturing, and a protocol that protects participants while the first human safety and dose information is collected.
How often should an AI model used in drug development be rechecked?
There is no universal interval. Reassessment should be triggered by changes in data sources, laboratory methods, patient populations, clinical practice, model version, or observed error patterns, with monitoring scaled to the consequences of a wrong output.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
